Loading…
Loading…
American Radium Society Appropriate Use Criteria: Radiation Therapy for Limited-Stage SCLC 2020
Chun, Stephen G., Simone, Charles B., Amini, Arya, Chetty, Indrin J., Donington, Jessica, Edelman, Martin J., Higgins, Kristin A., Kestin, Larry L., Movsas, Benjamin, Rodrigues, George B., Rosenzweig, Kenneth E., Slotman, Ben J., Rybkin, Igor I., Wolf, Andrea, Chang, Joe Y.
Published in Journal of thoracic oncology (01.01.2021)
Published in Journal of thoracic oncology (01.01.2021)
Get full text
Journal Article
Loading…
Phase 2 study of tarlatamab, a DLL3-targeting, half life-extended, bispecific T-cell engager (HLE BiTE) immuno-oncology therapy, in relapsed/refractory small cell lung cancer (SCLC)
Ramalingam, Suresh S., Ahn, Myung-Ju, Akamatsu, Hiroaki, Blackhall, Fiona Helen, Borghaei, Hossein, Hummel, Horst-Dieter, Johnson, Melissa Lynne, Reck, Martin, Zhang, Yiran, Jandial, Danielle, Cheng, Sunfa, Paz-Ares, Luis G.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Loading…
BIOLUMA: A phase II trial of nivolumab and ipilimumab in lung cancer-Results from the SCLC TMBhigh cohort
George, Julie, Calaminus, Andreas H., Schloesser, Hans Anton, Weber, Jan-Phillip, Brossart, Peter, Engel-Riedel, Walburga, Griesinger, Frank, Grohé, Christian, Kern, Jens, Nachtkamp, Kathrin, Panse, Jens Peter, Sebastian, Martin, Wiewrodt, Rainer Gerhard, Büttner, Reinhard, Thomas, Roman K., Wolf, Juergen
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Loading…
BIOLUMA: A phase II trial of nivolumab and ipilimumab in lung cancer—Results from the SCLC TMB high cohort
Fischer, Rieke Nila, George, Julie, Calaminus, Andreas H., Schloesser, Hans Anton, Weber, Jan-Phillip, Brossart, Peter, Engel-Riedel, Walburga, Griesinger, Frank, Grohé, Christian, Kern, Jens, Nachtkamp, Kathrin, Panse, Jens Peter, Sebastian, Martin, Wiewrodt, Rainer Gerhard, Büttner, Reinhard, Thomas, Roman K., Wolf, Juergen
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Loading…
Phase II study of roniciclib in combination with cisplatin/etoposide or carboplatin/etoposide as first-line therapy in subjects with extensive-disease small cell lung cancer (ED-SCLC)
Reck, M., Horn, L., Novello, S., Barlesi, F., Albert, I., Juhasz, E., Chung, J., Fritsch, A., Drews, U., Rutstein, M., Wagner, A., Govindan, R.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Loading…
Safety, tolerability, and preliminary efficacy results of a phase 1 study of LB2102, a dnTGFβRII armored DLL3-targeted autologous CAR-T cell therapy, in patients with relapsed or refractory small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC)
Sands, Jacob, Chiappori, Alberto, Creelan, Ben C., Schwarzenberger, Paul Otto, Koneru, Mythili, Vahora, Sahista, Davis, Christian, Xu, Da, Wang, Chuan, Munker, Reinhold, Hao, Zhonglin, Schoenfeld, Adam Jacob
Published in Journal of clinical oncology (01.06.2025)
Published in Journal of clinical oncology (01.06.2025)
Get full text
Journal Article
Loading…
Abstract 728: Early assessment of treatment effect in small cell lung cancer (SCLC) via ctDNA analysis
Jiang, John, Ju, Christine, Woestmann, Corinna, Balasubramanyam, Aarthi, Xi, Liu, Yaung, Stephanie J., Gattam, Sandeep, Hinzmann, Bernd, Thomas, Michael, Lasitschka, Felix, Meister, Michael, Schneider, Marc, Herth, Felix, Muley, Thomas, Wehnl, Birgit, Palma, John
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Loading…
Phase Ib/IIa study assessing the safety and efficacy of AL8326 monotherapy in patients with ≥3rd line small cell lung cancer (SCLC) treatment
Li, Xingya, Bi, Minghong, Su, Chunxia, Fang, Yong, WANG, Zibing, Yuan, Ying, Du, Xiuping, Lv, Tangfeng, Li, Yingyin
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Loading…
An open-label, multicenter, phase Ib/II study of the ATR inhibitor SC0245 in combination with irinotecan in patients with relapsed and refractory extensive stage small cell lung cancer (ES-SCLC)
Huang, Dingzhi, Pan, Hongming, Li, Chun-lai, Wang, Sheng, Guo, Hai-jun, Su, Rong, Zhang, Li-qin, Li, Shi-chang, Wang, Yi-wei, Hei, Yong-Jiang, Lu, Shun
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Loading…
Primary analysis from the phase 2 study of continuous talazoparib (TALA) plus intermittent low-dose temozolomide (TMZ) in patients with relapsed or refractory extensive-stage small cell lung cancer (ES-SCLC)
Goldman, Jonathan W., Cummings, Amy Lauren, Mendenhall, Melody A., Velez, Maria A, Babu, Sunil, Johnson, Tirrell T., Alcantar, Juan M., Dakhil, Shaker R., Kanamori, David E., Lawler, William E., Anand, Sidharth, Chauv, James, Garon, Edward B., Slamon, Dennis J.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Loading…
Integrated high-throughput analysis identifies super enhancers associated with chemoresistance in SCLC
Bao, Jiarong, Li, Man, Liang, Shumei, Yang, Yunchu, Wu, Jingfang, Zou, Qingqing, Fang, Shun, Chen, Size, Guo, Linlang
Published in BMC medical genomics (22.05.2019)
Published in BMC medical genomics (22.05.2019)
Get full text
Journal Article
Loading…
3100 Phase Ib/II study of the pan-cyclin-dependent kinase (CDK) inhibitor roniciclib (BAY 1000394) in combination with chemotherapy as first-line therapy in subjects with extensive disease small cell lung cancer (ED-SCLC)
Cho, B.C., Dy, G.K., Govindan, R., Kim, D.W., Pennell, N.A., Zalcman, G., Besse, B., Nogai, H., Rajagopalan, P., Ocker, M., Barlesi, F.
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Loading…
Loading…
1744P - Mutational profiling of tumour tissue and sequential plasma illustrates emergent clones during treatment in late stage small cell lung cancer (SCLC)
Yaung, S., Woestmann, C., Xi, L., Ju, C., Hinzmann, B., Thomas, M., Lasitschka, F., Meister, M., Schneider, M., Herth, F.J.F., Muley, T., Wehnl, B., Palma, J., Ma, X.M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Loading…
1744PMutational profiling of tumour tissue and sequential plasma illustrates emergent clones during treatment in late stage small cell lung cancer (SCLC)
Yaung, S, Woestmann, C, Xi, L, Ju, C, Hinzmann, B, Thomas, M, Lasitschka, F, Meister, M, Schneider, M, Herth, F J F, Muley, T, Wehnl, B, Palma, J, Ma, X M
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Loading…
Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675)
Albers, Elaine A.C., Zeng, Haiyan, De Ruysscher, Dirk K.M., Kuenen, Marianne A., Kessels, Rob, Hendriks, Lizza E.L., Belderbos, Jose S.A., Schagen, Sanne B.
Published in JTO clinical and research reports (01.05.2023)
Published in JTO clinical and research reports (01.05.2023)
Get full text
Journal Article
Loading…
CA184-156: A randomized, multicenter, double-blind, phase III trial comparing the efficacy of ipilimumab (Ipi) plus etoposide/platinum (EP) versus EP in subjects with newly diagnosed extensive-stage disease small cell lung cancer (ED-SCLC)
Spigel, David R., Zielinski, Christoph, Maier, Sabine, de Pril, Veerle, Fairchild, Justin P., Cuillerot, Jean-Marie, Reck, Martin
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Loading…
Abstract 7164: Exposure-efficacy and exposure-safety relationships of tarlatamab to inform dose selection and benefit-risk assessment in patients with advanced small cell lung cancer (SCLC)
Chen, Po-Wei, Minocha, Mukul, Kong, Stephanie M., Anderson, Erik S., Parkes, Amanda, Martinez, Pablo, Houk, Brett E., Lin, Chih-Wei
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article